Drug toxicity assessment: cell proliferation versus cell death
Elena V Sazonova1, Mikhail S Chesnokov1, Boris Zhivotovsky2,3
1Faculty of Medicine, MV Lomonosov Moscow State University, Moscow, Russia.
Cell Death Discovery
|October 14, 2022
Summary
Understanding how chemotherapy drugs affect tumor cells is crucial. This study clarifies mechanisms of cell death versus proliferation arrest, aiding in better drug development and toxicity analysis.
Area of Science:
- Pharmacology
- Cell Biology
- Biochemistry
Background:
- Chemotherapeutic drug toxicity analysis is vital in clinical pharmacology.
- Reduced tumor cell viability can indicate proliferation arrest or cell death, requiring precise differentiation.
Purpose of the Study:
- To elucidate the mechanisms underlying tumor cell response to chemotherapeutic drugs.
- To differentiate between proliferation arrest and cell death pathways induced by chemotherapy.
- To overcome uncertainties in assessing drug action mechanisms and toxicity.
Main Methods:
- Utilized various tumor cell lines for comprehensive analysis.
- Employed a combination of cell biological and biochemical methodologies.
- Conducted a detailed comparative analysis of cellular responses.
Main Results:
- Demonstrated distinct cellular processes mediating reduced cell numbers.
- Identified key differences between proliferation arrest and cell death.
- Provided insights into overcoming ambiguities in toxicity assessment.
Conclusions:
- Accurate differentiation of cell death vs. proliferation arrest is essential for understanding drug mechanisms.
- Integrated cell biological and biochemical approaches are necessary for robust analysis.
- This work offers strategies to improve the evaluation of chemotherapeutic drug efficacy and toxicity.
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...